AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
Ligand Pharmaceuticals initiates a program to develop contrast agents for Diagnostic Imaging Read more
Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases Read more